Archive for May, 2008
« Previous EntriesSubject Gsk Receives Positive Opinion For Conditional Approval Of New Oral Breast Cancer Treatment, Tyverb (lapatinib)
Saturday, May 31st, 2008GlaxoSmithKline (GSK) announced that the European Medicines Agency’s (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued a revised positive opinion confirming the positive benefit-risk profile for Tyverb® (lapatinib), GSK’s new oral treatment for breast cancer. The positive opinion recommends grant of a conditional marketing authorisation.The CHMP previously issued a positive opinion […]
Subject Safety And Efficacy Of Sunitinib In An Expanded-access Trial Of Metastatic Renal Cell Carcinoma (mrcc)
Friday, May 30th, 2008Today, UroToday.com - Sunitinib malate is an oral, multi-targeted tyrosine kinase inhibitor with direct anti-tumor and anti-angiogenic activities, internationally approved for the first-line treatment of advanced RCC. This international, open-label trial was undertaken to provide sunitinib to patients with advanced RCC who might benefit from therapy, but who had no access to the drug prior […]
Join The Fight Against Cancer Armstrong, White House Contenders Discuss Smoke-free Us (afp)
Friday, May 30th, 2008AFP - Seven-time Tour de France winner and anti-cancer advocate Lance Armstrong said Thursday he has discussed banning smoking in public places across the United States with the three White House contenders. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
Important Australia: Internet Promoting Teen Smoking
Thursday, May 29th, 2008A health expert says that popular internet sites including YouTube, Facebook and MySpace are being used to promote smoking to teenagers. University of Sydney public health professor Simon Chapman welcomed new figures showing that rates of youth smoking were down, but warned the internet was becoming the new battleground for new teen smokers. Prof Chapman […]
Subject Physical Job Activity May Cut Prostate Cancer Risk (reuters)
Wednesday, May 28th, 2008Reuters - Working in a job that requires a continuous level of high physical effort may decrease the likelihood of a man developing prostate cancer, researchers report. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover new web pages.
New Mouse Studies Identify Gene That May Influence Metastasis Risk In Breast Cancer
Wednesday, May 28th, 2008Researchers have identified a pattern of gene activity in mice that may help to predict individual risk for breast cancer metastasis and survival in humans. A single gene called bromodomain 4 (Brd4) regulates the expression of this pattern, also called a signature. The researchers found that one result of this Brd4 regulation is the suppression […]
Comments Requested Secondhand Smoke Damages Lungs: Novel Mri Technique Offers Proof
Tuesday, May 27th, 2008For the first time, researchers have identified structural damage to the lungs caused by secondhand cigarette smoke.The results of the study, conducted by researchers at the University of Virginia School of Medicine in Charlottesville and The Children’s Hospital of Philadelphia in Pennsylvania, were presented at the annual meeting of the Radiological Society of North America […]
Update Aicr Survey Uncovers Distorted Perceptions About What Causes Cancer
Monday, May 26th, 2008The most recent biennial survey commissioned by the American Institute for Cancer Research (AICR) shows that Americans rate cancer their number one health concern, believe it to be impossible to prevent, and continue to blame the disease on factors they cannot control. “These are three distressing, interconnected trends, and they help to explain something we […]
Subject Genetic Breast Cancer Test Approved (healthday)
Monday, May 26th, 2008HealthDay - WEDNESDAY, Jan. 16 (HealthDay News) — A new genetic test thathelps assess the risk of tumor recurrence and long-term survival forpatients with relatively high-risk breast cancer has been approved by theU.S. Food and Drug Administration. (Link)
This entry was important to me:
These icons link to social bookmarking sites where readers can share and discover […]
New Entry Molecular Insight Pharmaceuticals, Inc. Initiates Phase 2a Azedra(tm) Clinical Trial In Neuroblastoma Patients
Sunday, May 25th, 2008Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI) announced that it has initiated a Phase 2a clinical trial of Azedra (Ultratrace™ iobenguane I-131 or Ultratrace MIBG) for the treatment of children with high-risk neuroblastoma, a neuroendocrine cancer that primarily affects children. Azedra is already being evaluated in an ongoing dose-ranging clinical trial for pheochromocytoma in adults. (Link)
This […]